| Class 2 Device Recall 216 Wilson Frame Pads, Model 531937 | |
Date Initiated by Firm | March 28, 2017 |
Date Posted | April 19, 2017 |
Recall Status1 |
Terminated 3 on August 15, 2017 |
Recall Number | Z-1867-2017 |
Recall Event ID |
76920 |
Product Classification |
Operating Room Accessories Table Tray - Product Code FWZ
|
Product | 216 Wilson Frame Pads, Model # 5319-37;
Used with Radiolucent Wilson Frames, model numbers 5319G and 5321G.
General and Plastic Surgery: These pads are used as a component of the Wilson Frames, which support the torso of a prone patient during spine surgery. The pads are supplied with the frames and as replacements. |
Code Information |
All Lots: Manufacturing dates: December 2016 through March 2017; GTIN:00842430100192 |
Recalling Firm/ Manufacturer |
Mizuho OSI 30031 Ahern Ave Union City CA 94587-1234
|
For Additional Information Contact | Gina Costelli 800-777-4674 |
Manufacturer Reason for Recall | Mizuho has discovered that the 5319-37 Wilson Frame Pads have a design deficiency in the construction of their mounting sleeves that may allow the patient to contact the underlying carbon fiber structure of the Wilson frame and could lead to a pressure injury. |
FDA Determined Cause 2 | Process control |
Action | Letters were sent to customers and distributors on March 28, 2017 by Federal Express or UPS. Information is also posted on firm's web site. Frames having 5319-37 pads should not be used and all of the affected pads retrieved and destroyed. |
Quantity in Commerce | 216 sets |
Distribution | United States, Canada, Japan, Australia, New Zealand, Great Britain, Sweden, Spain, Germany, Switzerland, Kenya, Saudi Arabia, Hong Kong, South Korea. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|